Michael Louis Mastromauro

Works (4)

Updated: April 5th, 2024 10:45

2022 journal article

Doxorubicin for treatment of histiocytic sarcoma in dogs: 31 cases (2003-2017)

JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 260(14), 1827–1833.

By: R. Doka n, S. Suter n, M. Mastromauro n, A. Bennett n & P. Hess n

MeSH headings : Dogs; Animals; Histiocytic Sarcoma / veterinary; Retrospective Studies; Dog Diseases / diagnosis; Doxorubicin / therapeutic use; Treatment Outcome
TL;DR: Benefits of doxorubicin administration in canine HS are modest, with a limited ORR and delay in tumor progression, and are comparable to effects attained with other single-agent regimens. (via Semantic Scholar)
UN Sustainable Development Goal Categories
1. No Poverty (OpenAlex)
Sources: Web Of Science, NC State University Libraries
Added: February 6, 2023

2021 journal article

What is your diagnosis? Dermal mass in a dog

Veterinary Clinical Pathology, 51(1), 161–163.

By: J. Marin n, H. Mochizuki n, M. Mastromauro n & D. Stowe n

author keywords: ALP cytochemical stain; Canine; Cutaneous; Metastasis; Osteosarcoma
MeSH headings : Animals; Bone Neoplasms / veterinary; Dog Diseases / diagnosis; Dogs; Osteosarcoma / diagnosis; Osteosarcoma / veterinary
UN Sustainable Development Goal Categories
Sources: Web Of Science, ORCID, Crossref, NC State University Libraries
Added: November 5, 2021

2019 journal article

What is your diagnosis? Lymphocytes engulfing erythrocytes in a cat

Veterinary Clinical Pathology, 48(4), 768–770.

By: H. Mochizuki n, E. Sherrick n, M. Mastromauro n & D. Stowe n

author keywords: cell cannibalism; chronic lymphocytic leukemia; erythrophagia; feline; lymphoma
MeSH headings : Animals; Cat Diseases / diagnosis; Cat Diseases / pathology; Cats; Female; Leukemia, Lymphoid / diagnosis; Leukemia, Lymphoid / pathology; Leukemia, Lymphoid / veterinary; Lymphocytes
UN Sustainable Development Goal Categories
13. Climate Action (Web of Science)
Sources: Web Of Science, Crossref, NC State University Libraries, ORCID
Added: January 21, 2020

2017 journal article

Oral melphalan for the treatment of relapsed canine lymphoma

Veterinary and Comparative Oncology, 16(1), E123–E129.

By: M. Mastromauro n, S. Suter n, M. Hauck n & P. Hess n

author keywords: canine; chemotherapy; lymphoma; melphalan; rescue
MeSH headings : Administration, Oral; Animals; Antineoplastic Agents, Alkylating / administration & dosage; Antineoplastic Agents, Alkylating / adverse effects; Antineoplastic Agents, Alkylating / therapeutic use; Dog Diseases / drug therapy; Dogs; Female; Lymphoma / drug therapy; Lymphoma / veterinary; Male; Melphalan / administration & dosage; Melphalan / adverse effects; Melphalan / therapeutic use; Recurrence; Retrospective Studies
TL;DR: Although treatment resulted in limited clinical benefit and non-durable responses, oral melphalan was well-tolerated and may be a reasonable rescue option in cases where minimal effective agents remain. (via Semantic Scholar)
Sources: Web Of Science, ORCID, NC State University Libraries, Crossref
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.